Old Web
English
Sign In
Acemap
>
Paper
>
P095 AMISELIMOD SAFETY PROFILE FOR CROHN’S DISEASE, STRATIFIED BY PREVIOUS TREATMENT WITH ANTI-TNF AGENTS
P095 AMISELIMOD SAFETY PROFILE FOR CROHN’S DISEASE, STRATIFIED BY PREVIOUS TREATMENT WITH ANTI-TNF AGENTS
2020
Geert R. D’Haens
Neal E. Slatkin
Robert J. Israel
Zeev Heimanson
Keywords:
Tumor necrosis factor alpha
Diabetes mellitus
General surgery
Crohn's disease
Gastroenterology
Medicine
Internal medicine
Autoimmunity
Tumor necrosis factors
safety profile
Adverse effect
Ulcerative colitis
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]